Latest AI and machine learning research in dyslipidemia for healthcare professionals.
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined multisystem disease continuum characterized by the coexistence of metabolic dysfunction, cardiovascular disease, and chronic kidney disease (CKD). This study aimed to explore the relationship between the non-traditional lipid ratios and CKM syndrome. A cross-sectional analysis was performed using data from the 2007-2018 National Hea...
Diabetes, hypertension, and dyslipidemia are major risk factors for cardiovascular (CVD), cerebral, and renal diseases (RD). However, the underlying molecular mechanisms, particularly the biological paths linking these primary conditions to downstream diseases remain incompletely understood. In this study, we investigated the role of plasma proteins as mediators of secondary disease development us...
Alzheimer’s Disease and Related Dementias (ADRD) affect millions worldwide and can begin over a decade before symptoms appear. ADRD are generally irre...
Carotid atherosclerosis is a major contributor in the etiology of ischemic stroke. Although intraplaque hemorrhage (IPH) is known to increase stroke r...
Cardiovascular disease (CVD) screening faces significant challenges in resource-limited settings, where infrastructure and computational constraints p...
Frailty and multimorbidity are common in older adults and contribute substantially to prolonged hospitalizations, readmissions, and mortality. Yet, ex...
Arterial aging, marked by progressive vascular stiffening, is a contributor to cardiovascular disease. Photoplethysmography (PPG) waveforms offer an e...
Dementia poses an escalating global health burden, yet its underlying mechanisms remain incompletely understood. In this large-scale, targeted metabol...
Standard LDL-C equations were derived in cohorts largely untreated with modern combination diabetes therapies. With medication-treated patients compri...
Sleep disorders pose a major global health burden and are associated with a wide range of adverse health outcomes. Polysomnography (PSG) is the gold s...
Traditional LDL-C testing barriers—mandatory 9–12 hour fasting and inperson visits—disproportionately limit access for rural populations (60% of US co...
Obesity is a chronic, heterogeneous condition, with risks, trajectories, and treatment responses that vary widely among individuals. However, research...
Carotid ultrasound is routinely used in clinical practice for non-invasive vascular anatomical and functional assessment. In particular, the carotid i...
Alzheimer’s disease (AD) genome-wide association studies (GWAS), typically based on clinical phenotypes, have identified numerous risk loci, yet linki...
Postoperative new-onset deep vein thrombosis (PNO-DVT) of the lower extremities represents a prevalent and serious clinical complication following pel...
Alzheimer’s disease (AD) exhibits profound spatial heterogeneity in its molecular and pathological features, yet the basis of this regional selectivit...
Timely prognosis of type 2 diabetes (T2D) is critical for effective interventions and reducing economic burden. Longitudinal medical records offer pot...
Diabetes mellitus remains a major global health burden, causing an estimated 3.4 million deaths in 2024 and highlighting the need for accurate early i...
Bariatric surgery is an established treatment for obesity and its associated comorbidities, including diabetes, hypertension, sleep apnea, and hyperch...
BACKGROUND: Metabolic disorder and endothelial dysfunction (ED) are key events in the development and pathophysiology of atherosclerosis and are assoc...